Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q96PC2
UPID:
IP6K3_HUMAN
Alternative names:
Inositol hexaphosphate kinase 3
Alternative UPACC:
Q96PC2; Q96MQ9
Background:
Inositol hexakisphosphate kinase 3, alternatively known as Inositol hexaphosphate kinase 3, plays a crucial role in cellular processes by converting inositol hexakisphosphate (InsP6) to diphosphoinositol pentakisphosphate (InsP7/PP-InsP5) and 1,3,4,5,6-pentakisphosphate (InsP5) to PP-InsP4. This enzymatic activity is pivotal for the regulation of inositol phosphate signaling molecules, which are involved in various cellular functions.
Therapeutic significance:
Understanding the role of Inositol hexakisphosphate kinase 3 could open doors to potential therapeutic strategies. Its involvement in the intricate network of inositol phosphate signaling presents an opportunity for the development of novel treatments targeting cellular processes regulated by these signaling molecules.